Artículo de revista
Insulin resistance and polycystic ovary syndrome through life
Fecha
2012Registro en:
Current Pharmaceutical Design, Volumen 18, Issue 34, 2018, Pages 5569-5576
13816128
18734286
10.2174/138161212803307590
Autor
Diamanti-Kandarakis, Evanthia
Spritzer, Poli Mara
Sir Petermann, Teresa
Motta, Alicia Beatriz
Institución
Resumen
The heterogeneity of Polycystic Ovary Syndrome (PCOS) emphasizes the need for a consensual review of the data concerning its diagnosis and treatment and for determination of the relationship between the development of PCOS and the ethnic origin, the social status and the lifespan. Insulin resistance is an important characteristic in women with PCOS that aggravates features of PCOS. This review is focused in the diagnosis and treatment of insulin resistance and the risk factors for PCOS during childhood, adolescence and postmenopause. The role of endocrine disruptors and/or their interaction with PCOS have also been analyzed. © 2012 Bentham Science Publishers.